Some randomized controlled trials report modest improvements in pain and function, particularly in patients with mild-to-moderate knee OA, while others show minimal benefit compared to placebo (Chavda et al., 2022
You have a BMI over 27 and weight-related health concerns, such as high blood pressure, pre-diabetes, heart disease and raised cholesterol
This improved receptor expression has provided the ability to the recovery process from exercise, athletic injuries, and other soft tissue stressors
Case reports and small cohort studies describe women with endometriosis experiencing reduced pain and improved metabolic markers while on semaglutide or other GLP-1s prescribed for weight management or diabetes
This baseline production meets the needs of most healthy people with a balanced diet and without intensive exercise
In recent years, only approximately half of new drug approvals have been based on 2 or more adequate and well-controlled trials